Dr. Michael Schmidt Hodavance, MD

Dr. Hodavance practices at Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University.

Dr. Hodavance's NPI, 1790002186, was assigned on April 26, 2010. Dr. Hodavance graduated from Duke University School of Medicine in 2010. Dr. Hodavance holds Pennsylvania license MD460334.

Dr. Hodavance's primary practice is Lehigh Valley Hospital-Cedar Crest, at 1200 South Cedar Crest Boulevard, Allentown, PA 18103 in Lehigh County. The practice phone is (610) 402-8000.

Dr. Hodavance's primary practice is Lehigh Valley Hospital-Cedar Crest in Allentown, Pennsylvania, part of Thomas Jefferson University. Dr. Hodavance is also affiliated with Lehigh Valley Hospital-Pocono. The medical group on file is Lehigh Valley Physician Group (LVPG). Dmand AI also links Dr. Hodavance to 3 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hodavance practices, 5 sites in all. Vendor and product names are available with a free account.

Vascular and interventional radiology is Dr. Hodavance's primary specialty in the NPI Registry, under taxonomy code 2085R0204X. Dr. Hodavance is licensed in Pennsylvania.

CMS data shows 934 Medicare services from Dr. Hodavance across 31 procedure codes in 2024, for 604 Medicare patients. Medicare paid $59,977 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 604 Medicare patients who saw Dr. Hodavance in 2024. The largest group is 65 to 74, with 256 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hodavance's median patient age at 65, with 50% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 77 out of 100 for Dr. Hodavance for performance year 2024, reported as part of a group. Dr. Hodavance accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hodavance as offering telehealth.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Hodavance, published from 2015 to 2018. The most frequent topics are Carcinoma, Hepatocellular, Chemoembolization, Therapeutic and Liver Neoplasms. Dr. Hodavance's most frequent co-authors are Charles Yoon Kim, MD, Paul Vincent Suhocki, MD and Carl L. Berg, MD.

CMS Open Payments shows 116 general payments to Dr. Hodavance from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Terumo Medical Corporation paid the most, $1,190.

Dr. Hodavance graduated from Duke University School of Medicine in 2010.